Safilens builds up its European sales network

Safilens, the Italian contact lens company acquired by a pharmaceutical group in Rome two years ago, is working on processes that will allow its lenses to release vitamins and actual drugs into the eye. It is particularly keen on developing a process for the release of a beta blocker that ...

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.